Drug Eluting Stents: Higher Late Mortality in STEMI Patients Than Bare Metal: GRACE Registry Findings
/
RSS Feed
Gabriel Steg
Freek Verheugt
REFERENCE: Hotline III, number 709, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
GABRIEL STEG, Hôpital Bichat, Paris
COMMENT: FREEK VERHEUGT, Radboud University Nijmegen Medical Centre, Nijmegen
The GRACE registry looking at over 60 000 patients with ST elevation myocardial infarction has shown that patients live longer if they receive bare metal stents than if they get drug eluting stents. Gabriel Steg presented these latest data at the ESC meeting in Vienna. Sarah Maxwell discussed the findings with him.
Freek Verheugt comments on the interview with Gabriel Steg.
GABRIEL STEG, Hôpital Bichat, Paris
COMMENT: FREEK VERHEUGT, Radboud University Nijmegen Medical Centre, Nijmegen
The GRACE registry looking at over 60 000 patients with ST elevation myocardial infarction has shown that patients live longer if they receive bare metal stents than if they get drug eluting stents. Gabriel Steg presented these latest data at the ESC meeting in Vienna. Sarah Maxwell discussed the findings with him.
Freek Verheugt comments on the interview with Gabriel Steg.
